FDA doubtful on new Watchman data from Boston Scientific

The FDA expresses some doubts about new data from Boston Scientific on its Watchman anti-stroke device.

Boston Scientific, Food & Drug Administration (FDA)

News Well, Clinical Trials, Cardiac Implants, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vHLYBe